Matrix drug screening using a library of 1912 compounds crossed with birinapant found that histone deacetylase (HDAC) inhibitors (entinostat, panobinostat, vorinostat, romidepsin, and Trichostatin A) are highly synergistic with SMs in killing ovarian cancer cells [11]. The gene discussed is HDAC9; the disease is ovarian cancer.